✦ LIBER ✦

Pain in Myotonic Muscular Dystrophy, Type 1

✍ Scribed by Gregory T. Carter; Mark P. Jensen; Amy J. Hoffman; Brenda L. Stoelb; Richard T. Abresch; Craig M. McDonald

Book ID: 116237533
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 56 KB
Volume: 89
Category: Article
ISSN: 1532-821X
DOI: 10.1016/j.apmr.2008.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dysphagia in duchenne muscular dystrophy

Dysphagia in duchenne muscular dystrophy versus myotonic dystrophy type 1

✍ George Umemoto; Hirokazu Furuya; Akio Kitashima; Mitsuaki Sakai; Hajime Arahata; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

Familial clustering of muscular and card

Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1

✍ William J. Groh; Miriam R. Lowe; Zachary Simmons; Deepak Bhakta; Robert M. Pascu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Abstract Myotonic dystrophy type 1 (DM1) is associated with both skeletal and cardiac muscle involvement. The aim of the present study was to determine whether familial clustering is observed in the severity of muscle involvement in DM1. We evaluated 51 sibling groups constituting 112 patients w

Association of spinal and bulbar muscula

Association of spinal and bulbar muscular atrophy with myotonic dystrophy type 1

✍ Kenji Jinnai; Keisuke Nishimoto; Kyoko Itoh; Kozo Hashimoto; Keiichi Takahashi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Abstract A man with spinal and bulbar muscular atrophy (SBMA) had a short (CTG)n expansion in the myotonic dystrophy protein kinase gene as well as (CAG)n expansion in the androgen receptor gene in leukocytes. The patient had the characteristic clinical findings of SBMA, but none of myotonic dys

Peripheral neuropathy in myotonic dystro

Peripheral neuropathy in myotonic dystrophy type 1

✍ Mieke C. E. Hermans; Catharina G. Faber; Els K. Vanhoutte; Mayienne Bakkers; Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

Therapeutics development in myotonic dys

Therapeutics development in myotonic dystrophy type 1

✍ Erin Pennock Foff; Mani S. Mahadevan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

## Abstract Myotonic dystrophy (DM1), the most common adult muscular dystrophy, is a multisystem, autosomal dominant genetic disorder caused by an expanded CTG repeat that leads to nuclear retention of a mutant RNA and subsequent RNA toxicity. Significant insights into the molecular mechanisms of R

Cardiac abnormalities in myotonic dystro

Cardiac abnormalities in myotonic dystrophy type 1

✍ Josef Finsterer; Claudia Stöllberger 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB